We care to go beyond the obvious
We help healthcare players navigate transactions and unlock growth opportunities through market intelligence and strategic diligence
About us
Atain & Company is an independent advisory firm specializing in investment due diligence and value creation for innovative and growth-oriented companies.
We work with a variety of clients, from financial and strategic buyers looking to acquire and grow businesses, to entrepreneurs and corporates addressing strategic challenges. We help source deals and conduct due diligence to support investment issues. Post-deal, we build strategies that drive growth, efficiency, and competitiveness.
As investors ourselves, we are committed to having a sustainable impact and helping clients embed ESG in value creation to achieve lasting profitability and tangible social benefits
Our focus on life sciences
Health Care
We focus on manufacturers of innovative and generic medicines, providers of pharmaceutical services and health care IT solutions
Private Equity
We partner with private equity groups and financial investors to identify unique investment opportunities with strong market fundamentals.
Industrial Biotechnology
We provide commercial and strategic support to investors and businesses in the industrial and agricultural sectors of biomanufacturing and bioeconomy
“We support clients in acquiring healthcare companies and unlocking their full commercial potential.”
— Dr. Tetiana Kosten
Tetiana Kosten is the founder and director of Atain. She established the consultancy in 2020, supporting investors through the fast-paced post-pandemic investment surge.
Tetiana has 10 years of professional consulting experience, specialising in commercial due diligence and strategy. She developed a strong interest in healthcare investments while working at Roland Berger in Munich. Her track record is built on a foundation rigorously refined through over 50 due diligence projects, addressing investors’ requirements for both mature and early-stage companies.
Tetiana holds an MSc in Biotechnology from Shevchenko University in Kyiv and a PhD from the Max Delbrück Center and Free University in Berlin. She speaks English and German and is committed to promoting women’s entrepreneurship
Our services
We guide investors and industry players in identifying and selecting companies that will stand the test of time and generate shareholder value.
-
We guide investors and industry players with tailored commercial due diligence, leveraging deep expertise and a fact-driven approach to evaluate value, risks, and ensure strategic growth potential
-
We equip companies with strategies and value-creation plans to grow the core business and determine an approach for unlocking new strategic and operational potential
Latest news
We're proud to support our clients journey in building capabilities across their organizations, creating impact that extends beyond financial and operational success. Here’s a glimpse into that journey.
Private EquityPrivate markets health check: rebounding with strength in 2025
What headwinds and tailwinds are impacting fundraising, deal activity, value creation, and investment performance in private markets in 2024 and the year ahead
Insights • January 2025
Explore
Medical devicesOperational and legal due diligence on manufacturers of medical products
Learn how our due diligence services have helped clients across a wide range of products and geographies find quality, reliable, and financially viable manufacturers
Case study • August 2024
Explore
BiopharmaceuticalsEngaging payers in rare disease to prepare the market for gene therapy
The global pharma engaged us to assess how the company could interact with payers and payer advisory stakeholders to advance the field prior to launch
Case study • March, 2024
Explore
Seed InvestmentsTracing the origins of new ventures in intellectual property landscape
What challenges and opportunities are shaping Ukraine’s innovation landscape, and how can EU accession drive deeper technological advancements?
Report • August 2024
ExploreMORE OF OUR WORK
Our capabilities
Maximising the ESG Impact >
We aim to be a partner and advisor on ESG topics to drive economic growth that advances sustainability, resilience, and social inclusion. Learn how we help clients embed ESG considerations into their strategies to achieve clear differentiation and seize leadership opportunities
Collaborate. Innovate. Grow.
Join our network
We are proud to have built a network of thousands of industry experts who have held senior roles in private equity, venture capital, management, or the industry, and we are excited to bring their valuable expertise to our deals and projects. Are you interested in joining our team? Contact us!